share_log

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Farokhzad Omid

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Farokhzad Omid

Senti Biosciences | 4:持股变动声明-董事 Farokhzad Omid
美股sec公告 ·  07/12 16:22
Moomoo AI 已提取核心信息
On July 10, 2024, Farokhzad Omid engaged in a transaction involving Senti Biosciences, Inc. (SNTI). The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Farokhzad Omid to the issuer was also not specified. Without these details, the impact of this transaction on Farokhzad Omid's holdings and on Senti Biosciences remains unclear to investors.
On July 10, 2024, Farokhzad Omid engaged in a transaction involving Senti Biosciences, Inc. (SNTI). The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Farokhzad Omid to the issuer was also not specified. Without these details, the impact of this transaction on Farokhzad Omid's holdings and on Senti Biosciences remains unclear to investors.
2024年7月10日,Farokhzad Omid参与了涉及Senti Biosciences,Inc.(SNTI)的交易。在公告中未披露交易类型、状态、股份数量、股份性质、交易价格及股票总值等具体细节。Farokhzad Omid与发行人的关系也未明确。没有这些细节,这笔交易对Farokhzad Omid的持股和Senti Biosciences的影响对投资者来说仍然不清楚。
2024年7月10日,Farokhzad Omid参与了涉及Senti Biosciences,Inc.(SNTI)的交易。在公告中未披露交易类型、状态、股份数量、股份性质、交易价格及股票总值等具体细节。Farokhzad Omid与发行人的关系也未明确。没有这些细节,这笔交易对Farokhzad Omid的持股和Senti Biosciences的影响对投资者来说仍然不清楚。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息